E
Ultragenyx Pharmaceutical Inc. RARE
$39.34 $0.090.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 0.10% -1.46% 22.90% -38.55% 22.84%
Total Depreciation and Amortization 3.68% -1.18% 0.19% 7.63% 14.28%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -18.13% -8.43% 8.42% 52.73% -44.11%
Change in Net Operating Assets -26.20% 88.46% 129.20% -521.07% 375.14%
Cash from Operations -18.67% 12.95% 59.65% -127.32% 28.82%
Capital Expenditure 59.55% 19.51% 37.43% -100.69% 56.70%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 137.75% -537.70% -35.92% 192.63% -255.05%
Cash from Investing 137.29% -554.89% -35.87% 188.24% -266.45%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -23.67% -98.92% -- -- 1,210.18%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -100.00% 11,968.97% 200.00% -- --
Cash from Financing -71.49% -97.10% 663,787.93% -100.02% 1,210.18%
Foreign Exchange rate Adjustments -293.96% 296.76% 4.57% -161.56% 254.05%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 107.26% -189.71% 479.16% -168.92% 584.47%
Weiss Ratings